Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Country Of Origin Labeling Could Confuse Consumers, Increase OTC Costs

Oct 06 2008

• By Katie Stevenson

Related Content

FDA Failures During Heparin Crisis Drive Congress’ Stronger Drug Safety Push

May 05 2008

Country-Of-Origin Labeling Would Add Costs But No Consumer Benefit – CRN

Sep 29 2008

Drug Manufacturers’ Supply Options Could Be Constricted By Legislation

Aug 25 2008

Additional Topics

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window